What is Eikon Therapeutics, Inc. 's restricted cash?

Eikon Therapeutics, Inc. (EIKN) reported restricted cash of $400K in Q1 2026.

What does restricted cash mean?

Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.

Travel + LeisureTNL

$202M+12.8%

Liberty Broadband CorporationLBRDK

$973M—

Archer AviationACHR

$7.3M+12.3%

AstronicsATRO

$0-100%

AppFolioAPPF

$250K0.0%

American Healthcare REITAHR

$37.5M-9.4%

Operating income-$87.3M-22.3%

Net income-$83.0M-21.6%

EPS (diluted)-$2.46+90.9%

Cash & equivalents$161.2M-21.2%

Total debt$254.8M—

Total equity$550.7M+186%

Total assets$850.8M—

Operating cash flow-$89.8M-64.7%

CapEx$262.0K-98.8%

Free cash flow-$90.1M-17.1%

Market cap$521.35M—

Reported directly by Eikon Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RestrictedCashCurrent.

The official record: Eikon Therapeutics, Inc. ’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Connect your AI assistant and compare it to peers, right in your chat.

What is Eikon Therapeutics, Inc. 's restricted cash?: Eikon Therapeutics, Inc. (EIKN) reported restricted cash of $400K in Q1 2026.
What does restricted cash mean?: Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.